Mahkam Zanganeh

Co-CEO and President

CEO COO Other Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Summit Therapeutics Inc. (SMMT)	Co-Chief Executive Officer, President and Director	$616,500	$388,395	—	$245,021,384	—	$21,000	$246,047,279
2024	Summit Therapeutics Inc. (SMMT)	Co-Chief Executive Officer, President and Director	$600,000	$540,000	—	—	—	$21,021	$1,161,021
2023	Summit Therapeutics Inc. (SMMT)	Co-Chief Executive Officer, President and Director	$600,000	—	—	$19,905,115	—	$57,809	$20,562,924
2022	Summit Therapeutics Inc. (SMMT)	Co-Chief Executive Officer, President and Director	$450,000	$452,500	—	$307,200	—	$32,349	$1,242,049
2021	Summit Therapeutics Inc. (SMMT)	Director, Chief Executive Officer, and President	$450,000	$182,250	—	$8,987,768	—	$19,196	$9,639,214
2020	Summit Therapeutics Inc. (SMMT)	Director, co-Chief Executive Officer, and President	$49,615	—	—	$476,316	—	$1,381	$527,312

Executive changes

Appointed member of the Strategic Advisory Committee at Pulse Biosciences, Inc. (PLSE)
2024-08-09
Resigned Audit Committee of the Board at Pulse Biosciences, Inc. (PLSE)
2021-10-04

Earnings-call appearances

Summit Therapeutics Inc. Q1 FY2024 Earnings Call
Summit Therapeutics Inc. (SMMT)

2024-05-01
Summit Therapeutics Inc. Q2 FY2023 Earnings Call
Summit Therapeutics Inc. (SMMT)

2023-08-09
Summit Therapeutics Inc. Q1 FY2023 Earnings Call
Summit Therapeutics Inc. (SMMT)

2023-05-11